CRISPR Therapeutics AGNASDAQ:CRSP
- LAST PRICE47.2500
- TODAY'S CHANGE (%)0.4000 (0.8538%)
- Bid / Lots47.2500/ 26
- Ask / Lots47.8800/ 1
- Open / Previous Close47.6100 / 46.8500
- Day Range
- 52 Week Range
- Volume3,133,146
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRSP |
|---|---|---|
| 09:32 ET | 63145 | 47.4 |
| 09:33 ET | 19297 | 47.3352 |
| 09:35 ET | 15326 | 46.97 |
| 09:37 ET | 21957 | 46.735 |
| 09:39 ET | 23905 | 46.5504 |
| 09:42 ET | 33279 | 46.44 |
| 09:44 ET | 22977 | 46.536 |
| 09:46 ET | 16225 | 46.65 |
| 09:48 ET | 21480 | 46.7 |
| 09:50 ET | 18852 | 47.07 |
| 09:51 ET | 18091 | 47.115 |
| 09:53 ET | 22652 | 47.2 |
| 09:55 ET | 6839 | 47.097 |
| 09:57 ET | 33784 | 47.275 |
| 10:00 ET | 7836 | 47.275 |
| 10:02 ET | 5712 | 47.33 |
| 10:04 ET | 12613 | 47.2055 |
| 10:06 ET | 20286 | 47.13 |
| 10:08 ET | 10767 | 47.12 |
| 10:09 ET | 14797 | 47.095 |
| 10:11 ET | 18181 | 47.205 |
| 10:13 ET | 11764 | 47.15 |
| 10:15 ET | 8005 | 47.215 |
| 10:18 ET | 11140 | 47.17 |
| 10:20 ET | 9215 | 47.19 |
| 10:22 ET | 14920 | 47.105 |
| 10:24 ET | 19759 | 47.0853 |
| 10:26 ET | 24542 | 46.83 |
| 10:27 ET | 20395 | 47.16 |
| 10:29 ET | 10524 | 46.96 |
| 10:31 ET | 14587 | 47.04 |
| 10:33 ET | 14151 | 47.085 |
| 10:36 ET | 18651 | 46.93 |
| 10:38 ET | 18224 | 46.89 |
| 10:40 ET | 12972 | 47.055 |
| 10:42 ET | 15708 | 47.16 |
| 10:44 ET | 11356 | 47.15 |
| 10:45 ET | 4981 | 47.26 |
| 10:47 ET | 6241 | 47.04 |
| 10:49 ET | 17426 | 47.355 |
| 10:51 ET | 9931 | 47.31 |
| 10:54 ET | 4396 | 47.1 |
| 10:56 ET | 16939 | 46.845 |
| 10:58 ET | 27657 | 46.87 |
| 11:00 ET | 26128 | 47.155 |
| 11:02 ET | 15392 | 46.88 |
| 11:03 ET | 11361 | 46.92 |
| 11:05 ET | 17024 | 46.875 |
| 11:07 ET | 12241 | 46.965 |
| 11:09 ET | 9103 | 47.055 |
| 11:12 ET | 10077 | 47.01 |
| 11:14 ET | 16901 | 47.23 |
| 11:16 ET | 23844 | 47.4395 |
| 11:18 ET | 9916 | 47.525 |
| 11:20 ET | 6450 | 47.38 |
| 11:21 ET | 6024 | 47.5418 |
| 11:23 ET | 49054 | 47.765 |
| 11:25 ET | 29687 | 48.0705 |
| 11:27 ET | 14936 | 47.86 |
| 11:30 ET | 10266 | 47.78 |
| 11:32 ET | 7898 | 47.74 |
| 11:34 ET | 15460 | 47.76 |
| 11:36 ET | 4734 | 47.72 |
| 11:38 ET | 2640 | 47.66 |
| 11:39 ET | 4588 | 47.68 |
| 11:41 ET | 5562 | 47.62 |
| 11:43 ET | 8124 | 47.65 |
| 11:45 ET | 2436 | 47.75 |
| 11:48 ET | 3919 | 47.725 |
| 11:50 ET | 857 | 47.615 |
| 11:52 ET | 5992 | 47.725 |
| 11:54 ET | 17482 | 47.97 |
| 11:56 ET | 6072 | 48.2 |
| 11:57 ET | 2937 | 48.115 |
| 11:59 ET | 6870 | 48.24 |
| 12:01 ET | 4284 | 48.19 |
| 12:03 ET | 10496 | 48.285 |
| 12:06 ET | 15040 | 48.38 |
| 12:08 ET | 7387 | 48.02 |
| 12:10 ET | 3105 | 47.96 |
| 12:12 ET | 3169 | 47.76 |
| 12:14 ET | 1500 | 47.635 |
| 12:15 ET | 9656 | 47.7 |
| 12:17 ET | 3457 | 47.7049 |
| 12:19 ET | 6113 | 47.7565 |
| 12:21 ET | 6433 | 47.67 |
| 12:24 ET | 4838 | 47.72 |
| 12:26 ET | 1665 | 47.61 |
| 12:28 ET | 2658 | 47.63 |
| 12:30 ET | 2805 | 47.67 |
| 12:32 ET | 4534 | 47.56 |
| 12:33 ET | 8014 | 47.515 |
| 12:35 ET | 6956 | 47.575 |
| 12:37 ET | 2721 | 47.5 |
| 12:39 ET | 2227 | 47.525 |
| 12:42 ET | 3055 | 47.51 |
| 12:44 ET | 5283 | 47.3844 |
| 12:46 ET | 4880 | 47.52 |
| 12:48 ET | 5057 | 47.37 |
| 12:50 ET | 3562 | 47.341 |
| 12:51 ET | 4828 | 47.38 |
| 12:53 ET | 1606 | 47.38 |
| 12:55 ET | 2637 | 47.27 |
| 12:57 ET | 3720 | 47.1969 |
| 01:00 ET | 5107 | 47.17 |
| 01:02 ET | 4190 | 47.17 |
| 01:04 ET | 6413 | 47.13 |
| 01:06 ET | 1235 | 47.04 |
| 01:08 ET | 3375 | 47.1 |
| 01:09 ET | 4511 | 47.15 |
| 01:11 ET | 3410 | 47.1 |
| 01:13 ET | 3104 | 47.11 |
| 01:15 ET | 1691 | 47.14 |
| 01:18 ET | 6207 | 47.15 |
| 01:20 ET | 5645 | 47.0142 |
| 01:22 ET | 6282 | 47.11 |
| 01:24 ET | 2692 | 47.09 |
| 01:26 ET | 1126 | 47.075 |
| 01:27 ET | 3684 | 47.05 |
| 01:29 ET | 8846 | 47.155 |
| 01:31 ET | 1462 | 47.185 |
| 01:33 ET | 5500 | 47.135 |
| 01:36 ET | 7305 | 47.0786 |
| 01:38 ET | 3298 | 47.12 |
| 01:40 ET | 4217 | 47.095 |
| 01:42 ET | 7821 | 47.13 |
| 01:44 ET | 7161 | 47.1 |
| 01:45 ET | 7065 | 47.175 |
| 01:47 ET | 2916 | 47.17 |
| 01:49 ET | 4677 | 47.145 |
| 01:51 ET | 2078 | 47.09 |
| 01:54 ET | 4099 | 47.06 |
| 01:56 ET | 5788 | 47.045 |
| 01:58 ET | 17523 | 47.07 |
| 02:00 ET | 4375 | 47.125 |
| 02:02 ET | 2305 | 47.1 |
| 02:03 ET | 3912 | 47.05 |
| 02:05 ET | 3923 | 47.05 |
| 02:07 ET | 2990 | 47.06 |
| 02:09 ET | 5632 | 47.21 |
| 02:12 ET | 10663 | 47.21 |
| 02:14 ET | 2730 | 47.087 |
| 02:16 ET | 4339 | 47.08 |
| 02:18 ET | 17789 | 47.04 |
| 02:20 ET | 3808 | 47 |
| 02:21 ET | 12751 | 47.025 |
| 02:23 ET | 1674 | 47 |
| 02:25 ET | 2567 | 47.015 |
| 02:27 ET | 17251 | 47.18 |
| 02:30 ET | 12562 | 47.07 |
| 02:32 ET | 8456 | 47.0165 |
| 02:34 ET | 4422 | 47.1 |
| 02:36 ET | 4730 | 47.15 |
| 02:38 ET | 6672 | 47.08 |
| 02:39 ET | 2759 | 47.1 |
| 02:41 ET | 5525 | 47.12 |
| 02:43 ET | 5409 | 47.24 |
| 02:45 ET | 1006 | 47.2043 |
| 03:14 ET | 400 | 47.275 |
| 03:15 ET | 5001 | 47.255 |
| 03:17 ET | 19389 | 47.225 |
| 03:19 ET | 7554 | 47.19 |
| 03:21 ET | 7018 | 47.18 |
| 03:24 ET | 2393 | 47.18 |
| 03:26 ET | 4302 | 47.195 |
| 03:28 ET | 4362 | 47.1167 |
| 03:30 ET | 5523 | 47.15 |
| 03:32 ET | 8584 | 47.16 |
| 03:33 ET | 4244 | 47.25 |
| 03:35 ET | 5292 | 47.25 |
| 03:37 ET | 5941 | 47.28 |
| 03:39 ET | 7661 | 47.315 |
| 03:42 ET | 5990 | 47.29 |
| 03:44 ET | 8538 | 47.215 |
| 03:46 ET | 7654 | 47.2 |
| 03:48 ET | 12863 | 47.235 |
| 03:50 ET | 16682 | 47.2 |
| 03:51 ET | 22492 | 47.235 |
| 03:53 ET | 18547 | 47.25 |
| 03:55 ET | 34669 | 47.14 |
| 03:57 ET | 32570 | 47.24 |
| 04:00 ET | 307060 | 47.25 |
Nov 14, 2024
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 7, 2024
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
DJ Crispr Therapeutics Price Target Maintained With a $53.00/Share by RBC Capital, from 11:28AM ET on Wednesday Nov 06, 2024 by Dow Jones
11:28AM ET on Wednesday Nov 06, 2024 by Dow JonesDJ Crispr Therapeutics Is Maintained at Equal-Weight by Barclays, from 9:29AM ET on Wednesday Nov 06, 2024 by Dow Jones
9:29AM ET on Wednesday Nov 06, 2024 by Dow JonesDJ Crispr Therapeutics Price Target Maintained With a $84.00/Share by Needham, from 5:41AM ET on Wednesday Nov 06, 2024 by Dow Jones
5:41AM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CRISPR Therapeutics AG | 4.0B | -16.9x | --- |
Denali Therapeutics Inc | 4.1B | -9.1x | --- |
Apellis Pharmaceuticals Inc | 3.5B | -12.9x | --- |
Ultragenyx Pharmaceutical Inc | 4.4B | -6.9x | --- |
Amicus Therapeutics Inc | 3.0B | -28.0x | --- |
Veracyte Inc | 2.8B | -248.8x | --- |
Company Information
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Contact Information
- Headquarters
- Baarerstrasse 14ZUG, ZUG, Switzerland 6300
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Samarth Kulkarni
- Chief Financial Officer
- Raju Prasad
- Chief Operating Officer
- Julianne Bruno
- General Counsel, Secretary
- James Kasinger
- Chief Medical Officer
- Naimish Patel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
|---|---|
Revenue (TTM) | $202.8M |
Shares Outstanding | 85.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.60 |
EPS | $-2.80 |
Book Value | $23.52 |
P/E Ratio | -16.9x |
Price/Sales (TTM) | 19.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -163.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
